The generation and metabolism of bioactive peptides involves a series of highly ordered proteolytic events. This post-translational processing can occur either within the cell, at the cell surface or after secretion. In the central nervous system a number of extracellular peptidases have been implicated in the regulated processing of peptides, particularly in the regulation of neuroendocrine function. The aim of this study has been to identify the peptidases involved in the metabolism of gonadotropin-releasing hormone (GnRH) and to characterize the factors and the mechanisms by which the activity of these peptidases are regulated. We have shown that both prolylendopeptidase and the thimet oligopeptidase EC 3.4.24.15 are involved in GnRH metabolism and that both oestrogen and thiol-based reductants could be involved in the physiological regulation of their activities.
Introduction
The generation of bioactive peptides from highermolecular-mass inactive precursors involves a series of highly ordered proteolytic events mediated by specific 'processing peptidases '.
These post-translational processing events can occur within the cell, at the cell surface, in the extracellular environment and within the circulation. The intracellular processing of peptidases is thought to occur primarily within the secretory Key words: gonadal axis, gonadotropin-releasing hormone, oestrogen, prolylendopeptidase. Abbreviations used: CSF, cerebrospinal fluid; GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; ME, median eminence: OW, ovariectomized; PEP, prolylendopeptidase; QFS, quenched fluorescemt substrate . 'To whom correspondence should be addressed (e-mail ian.smith@ baker.edu.au).
pathway and seems to be mediated largely by members of the subtilisin family of serine proteases (reviewed in [l] ). However, it is thought that, at the cell surface, membrane-associated enzymes are the prime mediators of peptide processing events. In this context the membraneassociated thermolysin-like metallopeptidases have been shown to have a vital role in the regulation of cardiovascular and endocrine function.
Over the past 10 years, evidence has started to accumulate to support a physiological involvement for the soluble neutral metallopeptidases in the regulation of both central and peripheral peptide activity [2] . The soluble thimet oligopeptidase (EC 3.4.24.15 ) is a neutral zinc metallopeptidase within the family containing a His-Glu-Xaa-XaaHis (HEXXH) Zn2+-binding motif. This enzyme is a true peptidase and only cleaves short (less than 20 residues) substrates, preferentially cleaving on the carboxy side of hydrophobic amino acids with an additional preference towards an aromatic or basic residue in the S1 position or the P1 and P2 positions (nomenclature of Schechter and Berger). Residues upstream and downstream of the scissile bond influence specificity; for example, a Phe or Tyr residue in the P3 position greatly increases the binding affinity for the substrate and rate of reaction [3] .
Unlike the other thermolysin-like metalloendopeptidases, thimet oligopeptidase is activated by low thiol levels (less than 1 mM dithiothreitol) and inhibited by higher thiol levels (more than 5 mM dithiothreitol) [4] . We have recently shown that this mechanism of activation by rhiol-containing reducing compounds involves the conversion of inactive multimers, in which substrate access to the catalytic site is restricted, into the active mnomeric species in which substrate access is not hindered [S] . In addition, we have identi-fied the precise cysteine residues (Cys-246, Cys-248, Cys-253) involved in the formation of these multimeric forms. Cysteine residues 246 and 253 are unique to thimet oligopeptidase on the basis of a sequence comparison with the closely related but non-thiol-activated neurolysin (EC 3.4.24.16) . A double mutant of thimet oligopeptidase (C246S/C253S) and a triple mutant (C246S/C248S/C253S) exhibit the same degree of intrinsic activity and lack of activation in response to thiol agents [5] . We believe that this mechanism of activation might be crucial for the physiological regulation of thimet oligopeptidase activity, both within the cell and at the cell surface.
Thimet oligopeptidase is widely distributed in cells and tissues throughout the body. High levels have been localized, both catalytically and immunohistochemically, to the brain, pituitary and testis, with lower levels in other tissues such as the liver, kidney, spleen and lung [6] . The distribution of thimet oligopeptidase in areas rich in neuropeptide content is consistent with a role for this enzyme in the processing/metabolism of bioactive peptides. There is strong evidence to suggest that thimet oligopeptidase might be of importance in the central regulation of rqproductive function. Gonadotrophin-releasing hormone (GnRH) is released from the median eminence (ME) of the hypothalamus directly into the hypophysioportal blood system and carried to the anterior pituitary, where it stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone into the circulation. Several lines of evidence support a role for thimet oligopeptidase in modulating the GnRH signal to the pituitary. Thimet oligopeptidase activity has been shown to be much higher in the rat ME, anterior pituitary and the preoptic area of the hypothalamus than in other brain regions [7], the hypothalamus being the major site of GnRH synthesis. These tissues, and in particular the ME, also exhibited high levels of thimet oligopeptidase in the sheep hypothalamic-pituitary axis [8] . In addition, thimet oligopeptidase has been detected in hypophysial portal blood and its immunoreactivity detected in regions of the ME in which both GnRH axons and hypophysial portal vessels are present [9], suggesting that thimet oligopeptidase is secreted within the ME and is thus perfectly placed to regulate the GnRH signal.
However, we have shown that thimet oligopeptidase cleaves GnRH very slowly, unless the C-terminal glycinamide has been removed by a prolylendopeptidase (PEP) [ 101. Although both enzymes can degrade GnRH in vitro and are located in both the ME and the pituitary, it is still unknown whether they contribute to the regulation of GnRH in the hypothalamic-pituitary axis in vivo.
The mechanisms involved in mediating the functional changes in both hypothalamic GnRH neurons and pituitary gonadotropes required to produce the LH surge are not fully understood but it is clear that feedback regulation by gonadal steroids has a major role [l 11. This raises the possibility that the activity of GnRH-cleaving peptidases might also be modulated across the oestrous cycle, such that degradation of GnRH might be decreased before and/or during the LH surge so as to maximiae areleasing factor levels seen by the oestrogen-primed pituitary. Indeed, hypophysial portal concentrations of GnRH are constantly elevated during the LH surge [12] . Furthermore, it has been demonstrated that the relatively stable endogenous breakdown product of GnRH can function as a N-methyl-D-aspartate receptor antagonist, selectively inhibiting the GnRH secretion evoked by N-methyl-D-aspartate [13] . Given that the combined action of thimet oligopeptidase and PEP on GnRH generates the GnRH(1-5) fragment, one could speculate on an important role for thimet oligopeptidase in the regulation of the glutamate-induced GnRH release at these receptors.
In the present study we used specific, fluorescence-based assays to look for endogenous activators of thimet oligopeptidase in sheep plasma and cerebrospinal fluid (CSF) and examined the relationship between GSH concentration and the degree of activation of thimet oligopeptidase. In addition, we used these assays to quantify the activity of both PEP and thimet oligopeptidase in individual sheep MEs derived from ewes at various stages of the oestrous cycle.
Materials and methods

Animals
Mature Corriedale ewes were used throughout the study. and checked daily for oestrous behaviour. Day 0 was taken as the day of oestrus. Animals killed durimg the luteal phase (n = 13) were between days 10 and 12 of the cycle. Follicular phase animals were killed either 24 h (mid-follicular phase, n = 12) or 36 h (late follicular phase, n = 8) after the injection of Cloprostenol. Animals were also killed at approximately the time of the preovulatory LH surge (n = 13) as determined by the measurement of plasma LH levels.
CSF was extracted under gravity from the left ventricle of conscious sheep by the method of Walsh and Clarke [14] . All experimental protocols were approved by the Animal Ethics Committees of Monash Medical Centre and the Victorian Institute of Animal Science, and were performed in accordance with the National Health and Medical Research Council of Australia guidelines for animal experimentation. 
Enzyme assays
Prolylendopeptidase PEP was assayed by the method of Kato et al. [16] (with minor modifications), with the fluorogenic substrate succinyl-Gly-Pro-4-methyl-coumaryl-7-amide.
Thimet oligopeptidase
Thimet oligopeptidase activity in ME extracts was assayed with a specific quenched Auorescent substrate (QFS), 7-methoxycoumarin-4-acetyl-ProLeu-Gly-Pro-~-Lys(2,4-dinitrophenyl), similar to that described by Tisljar et al. [17] . For the activation studies, both recombinant wild-type and double-mutant (C246S/C253S) thimet oligopeptidases were assayed with the QFS assay in 1 ml each of CSF, plasma, serum, 1 mM GSH and the low-molecular-mass fraction of CSF (less than 10 kDa) obtained by the use of a 10 kDa cut-off Microcon centrifugal ultrafilter. For the GSH experiment, recombinant thimet oligopeptidase (0.5 pg) was assayed in duplicate in 2.5 ml of Trisbuffered saline, pH 7.4, containing increasing concentrations of GSH: 0, 0.01, 0.05, 0.10, 0.50, 1 .O, 10 mM. The substrate volume was 20 pl.
statistical analysis
Levels of thimet oligopeptidase and PEP activity in MEs were expressed as pmol of product formed/h per pg of tissue protein for analysis. Enzyme activities at different phases of the oestrous cycle were compared with conventional analysis of variance followed by specific multiple comparisons. The Dunn-Sidak correction was applied to protect against the increased risk of type I error 34 by adjusting the P value to P ' by the formula P ' = 1 -(1 -P)', where k is the number of comparisons made. Comparisons of enzyme activity in MEs from ovariectomized (OVX) and oestradiol-treated OVX ewes were made by using a two-tailed unpaired Student's t test. P < 0.05 was considered significant.
Results
T o identify possible endogenous activators or inhibitors of thimet oligopeptidase we assayed both recombinant wild-type and double-mutant thimet oligopeptidase (C246S,C253S) activity in the presence of sheep plasma, serum, CSF, a lowmolecular-mass fraction of CSF (less than 10 kDa) or 1 mM GSH (Table 1) . We found that both GSH and CSF enhanced thimet oligopeptidase activity, although the latter did so only modestly. However, a low-molecular-mass fraction of CSF, obtained through the use of a 10kDa cut-off Microcon centrifugal ultrafilter, substantially activated thimet oligopeptidase activity to a level similar to that seen with GSH. This result suggests that CSF contains both activating and inhibitory characteristics for thimet oligopeptidase ; this observation was supported by the inhibition of the intrinsically active double mutant. Interestingly, the activity of the double mutant was not altered by GSH or the low molecular mass CSF fraction, suggesting that the observed thimet oligopeptidase activation occurs through disulphide bond disruption involving Cys-246, Cys-248 and Cys-253. T o examine the possibility that GSH at physiological concentrations is capable of regulating thimet oligopeptidase activity, we examined the activation of thimet oligopeptidase by GSH over a range of concentrations (Figure 1) . GSH activated thimet oligopeptidase in a dose-dependent manner; maximal activation was observed at a GSH concentration of 1 mM, whereas higher concentrations such as 5-10 mM abolished thimet oligopeptidase activity.
Levels of thimet oligopeptidase activity in the ME did not vary across the oestrous cycle (Table  2) , and although PEP activity levels tended to be lower at the time of the L H surge, the decrease was not significant (Table 2) . PEP activity was significantly lower (P = 0.02) in ME from oestrogentreated OVX ewes (1.71 f0.19 pmol/h per pg, n = 4) than in those from untreated OVX ewes (2.10k0.12 pmol/h perpg, n = 8; results given as means+ S.E.M.), but was not different between intact and OVX ewes (results not shown).
Discussion
These studies have shown for the first time that sheep CSF contains two components capable of activating thimet oligopeptidase, one highmolecular-mass protein component (more than 10 kDa) and one low-molecular-mass non-protein component (less than 10 kDa). These activating components were constant in both the appearance and degree of thimet oligopeptidase activation between CSF samples. GSH, the most prevalent cellular thiol, activated thimet oligopeptidase maximally at 1 mM and inhibited it at higher concentrations such as 2-10 mM, the same pattern as that seen with dithiothreitol [4] . GSH concentrations within the cell range from 1 to 1 0 m M ; fluctuating GSH concentrations could therefore conceivably regulate the intracellular activity of thimet oligopeptidase.
The degradation of neuropeptide transmitters is crucial to the termination of peptidergic signalling, in a manner analogous to acetylcholinesterases at the neuromuscular junction. The possible role of peptidases in the control of GnRH levels in the hypothalamic-pituitary axis, and the potential for the physiological regulation of these enzymes, has been examined by several groups [18, 19] . However, the results generated so far cannot be considered definitive. Reports of candidate peptidases have been frequent but, until recently, the characterization of these activities has been performed on very crude preparations Table 2 Activity of thimet oligopeptidase and PEP in extracts of sheep ME at different phases of the oestrous cycle Enzyme activlty levels were measured in extracts from individual sheep MEs by using specific fluorescence assays. Values are expressed in pmol of produdh perpg of protein and are meansfS.E.M. N o significant differences in activity between the different phases ofthe oestrous cycle were found for either enzyme (ANOVA followed by the Dunn-Sidak correction for multiple comparisons). that clearly contain more than one peptidase activity. In the search for enzymes that metabolize GnRH, several putative peptidases have been reported but only one, thimet oligopeptidase, has been sequenced and cloned [20] .
To examine further the role of thimet oligopeptidase and PEP in regulating gonadal function we have specifically examined their activities during the sheep oestrous cycle. T o achieve this we used specific fluorescence-based assays to measure the activity of thimet oligopeptidase and PEP extracts of individual ME derived from ewes killed at different phases of the oestrous cycle, and from OVX animals treated with oestradiol. Overall our results suggest that PEP activity in the ME tended to be lower during the LH surge, particularly in the oestradiol-treated OVX ewe, whereas thimet oligopeptidase levels did not change (Table 2) . However, the fall in PEP activity was modest and is unlikely to have contributed significantly to increased GnRH levels reaching the pituitary during the LH surge. Although levels of GnRH-degrading enzymes in the ME do not seem to change across the oestrous cycle, they might still be important in terminating the GnRH signal to the pituitary.
Taken together, our results suggest that any regulation of peptidase activity within the hypothalamic-pituitary-gonadal axis is likely to occur via endogenous regulators of peptidase activity such as GSH or via protein thiol regulators such as thioredoxin and/or other protein disulphide isomerases rather than simply via changes in protein expression levels. Further studies are now required, both to allow the precise identification of these factors and to define their possible role in regulating reproductive function.
